Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.
暂无分享,去创建一个
Y. Kitamura | T. Sendo | A. Sasaki | Y. Soga | M. Kajizono | T. Higuchi | M. Muro | A. Sasaki
暂无分享,去创建一个
Y. Kitamura | T. Sendo | A. Sasaki | Y. Soga | M. Kajizono | T. Higuchi | M. Muro | A. Sasaki